Dual Perspectives in Psoriatic Disease Management: Zero Disease Activity in One or More Domains

Exhibit Hall, Hall F2, Innovation Theater A | Developed and offered by UCB, Inc.

---

Program Description

UCB is excited to host a commercial product theater symposium at ACR this year, highlighting dual perspectives in disease management. You’ll also have the opportunity to hear real-world patient experiences from peers who have used BIMZELX^® (bimekizumab-bkzx) through in-booth Q&A sessions at Booth #1101.

At the product theater, experts will discuss addressing patient and provider goals in disease management. The in-booth mini-presentations and Q&A sessions will feature HCPs sharing real-world patient experiences with BIMZELX and answering your questions. For more information on UCB’s commitment, please visit the link below.

Learn how UCB is committed to enhancing patient care

BIMZELX^® is a registered trademark of the UCB Group of Companies.
©2025 UCB, Inc., Smyrna, GA 30080. All rights reserved. 10/2025 US-BK-2501187

Speakers:

Presenter: Philip J. Mease, MD
Providence Swedish Health
Rheumatology
Director of Research
Seattle, Washington

Presenter: Clive Liu, MD
University of Washington
Dermatology
Adjunct Faculty
Seattle, Washington

Presenter: Hillary Norton, MD
Inspire Santa Fe Medical Group
Rheumatology
Owner, Board Certified Rheumatologist
Santa Fe, New Mexico

Presenter: Bret Sohn, MD
Stamford Hospital
Rheumatology
Division Director of Rheumatology
Stamford, Connecticut